Chemo Drugs: Reducing Rem Sleep?

Sleep is a complex cognitive state that is affected by medications in many different ways. There are more than 90 sleep disorders, each with clear diagnostic criteria. Sleep disorders can be divided into three groups: those producing insomnia, those causing daytime sleepiness, and those disrupting sleep. Chemotherapy drugs can affect sleep stages and cause sleep disorders or exacerbate the effect of chronic illnesses on sleep. For example, benzodiazepines, which are frequently used to treat insomnia, may cause a withdrawal syndrome with REM rebound. Other drugs that decrease REM sleep include ethanol, tricyclic antidepressants, trazodone, selective serotonin reuptake inhibitors (SSRIs), amphetamines, methylphenidate, and clonidine.

REM sleep and the impact of antidepressants

Sleep is a complex cognitive state that can be affected by medications in a variety of ways. Antidepressants are one such medication that can have a significant impact on sleep, particularly REM sleep.

Antidepressants are often used to treat insomnia, with some studies suggesting that they can improve sleep quality and duration. However, it is important to note that not all antidepressants have the same effects on sleep. Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), for example, have been found to suppress REM sleep and increase REM sleep latency. This can lead to issues such as daytime sleepiness and a decreased quality of life. On the other hand, sedating antidepressants such as mirtazapine and trazodone can improve sleep by reducing sleep latency and improving sleep efficiency.

The impact of antidepressants on REM sleep is not yet fully understood, and it may depend on various factors such as the type of antidepressant, dosage, time of administration, and duration of treatment. Additionally, individual differences in patients, such as age and the presence of other medical conditions, may also play a role in the effects of antidepressants on REM sleep. Further research is needed to fully understand the complex relationship between antidepressants and REM sleep.

It is worth noting that while antidepressants may disrupt sleep in the short term, they can improve sleep in the long term by treating the underlying depression. Therefore, it is crucial for physicians to carefully consider the potential benefits and drawbacks of using antidepressants to treat sleep disorders, especially when used in combination with other sleep-inducing medications.

REM sleep and the role of melatonin

Sleep is a complex cognitive state that can be divided into three groups of disorders: those producing insomnia, those causing daytime sleepiness, and those disrupting sleep. Medications can be used to treat these disorders, but they can also be a cause of them.

Rapid eye movement (REM) sleep is one of the sleep stages that can be affected by medications. It is known to play a role in learning and memory consolidation. REM sleep behaviour disorder (RBD) is a parasomnia characterised by loss of the muscle paralysis that usually occurs during REM sleep. This can result in patients acting out their dreams, sometimes violently. RBD is associated with various conditions, including depression, and can be treated with medications that suppress REM sleep, such as benzodiazepines and antidepressants.

Melatonin is a hormone that regulates sleep-wake cycles and circadian rhythms in the central nervous system. It has been shown to influence human physiology, including the sleep-wake cycle, in a time-dependent manner via the body's internal clock. Exogenous melatonin has been found to increase REM sleep continuity and promote a decline in rectal temperature during sleep. In one study, patients with neuropsychiatric sleep disorders and reduced REM sleep duration who were administered 3 mg of melatonin daily for four weeks experienced significant increases in REM sleep percentage and improvements in subjective measures of daytime dysfunction. These results suggest that exogenous melatonin can help normalise circadian variation in human physiology and may have a strong impact on general health, especially in the elderly and shift workers.

In summary, REM sleep plays an important role in brain function and immune system function, and disruptions to it can be treated with medications that suppress REM sleep or, in some cases, with exogenous melatonin.

REM sleep and the impact of antihistamines

Antihistamines are commonly used to treat insomnia, but they can have unintended side effects on REM sleep.

Classic antihistamines, such as chlorpheniramine, mepyramine, and diphenhydramine, are known to produce drowsiness by blocking H1 histamine receptors (H1R) in the brain. This leads to an increase in non-rapid eye movement (NREM) sleep and a decrease in REM sleep. However, higher doses of these antihistamines can have the opposite effect, decreasing NREM sleep and causing insomnia.

Second-generation antihistamines, such as cetirizine, are designed to have reduced permeability through the blood-brain barrier, making them less likely to cause drowsiness. While these modern antihistamines do not produce drowsiness at typical clinical doses, higher doses can still increase NREM sleep and decrease REM sleep.

The use of antihistamines as sleep aids is generally not recommended due to their side effects, which include altered mental state, urinary retention, and dry mouth. Additionally, antihistamines can lead to sleepwalking and other parasomnias. They may also cause hyperactivity, especially in children, and people can develop a tolerance to their sleep-inducing effects very quickly.

While antihistamines can help with falling asleep, they do not improve overall sleep quality. Therefore, it is advisable to consult a physician or sleep specialist to address long-term insomnia, as it could be a symptom of underlying medical issues.

REM sleep and the impact of stimulants

Sleep is a complex and highly organised biological state, and stimulants can have a significant impact on sleep in several ways. Stimulants are drugs that produce a temporary increase in energy, alertness, heart rate, and respiration. They affect the entire central nervous system and can be addictive due to the feeling of euphoria they create. While people who take stimulants for mental health reasons may experience little to no effects on sleep, those who abuse stimulants may find it challenging to fall asleep.

Stimulants can affect sleep by increasing wakefulness and physical activity, making it difficult to fall asleep and reducing overall sleep time. They can also lead to a lack of restorative REM sleep, which is essential for repairing pathways in the brain. This can result in insomnia and sleep disturbances that are sometimes severe enough to disrupt treatment success and cause or worsen anxiety, depression, or chronic stress. Additionally, stimulants can cause poor nutrition, which in turn can negatively impact sleep quality.

The impact of stimulants on sleep can be so significant that some individuals may continue using them just to maintain their regular sleep schedule. This can lead to a cycle of stimulant addiction and withdrawal symptoms, including cravings and negative mental and physical health effects.

When it comes to managing the impact of stimulants on sleep, treatment options such as sleep medications, relaxation techniques, and behavioural therapy can be helpful. However, the safest and most effective approach is to address the underlying stimulant addiction through a comprehensive addiction treatment program.

REM sleep and the impact of sedatives

Sleep is a complex and multifaceted cognitive state that is affected by various medications, including sedatives. While sedatives are commonly used to treat insomnia, it is important to understand their impact on different stages of sleep, including REM sleep.

Sedatives, such as benzodiazepines, are often prescribed to induce sleep and treat insomnia. Benzodiazepines act on gamma-aminobutyric acid (GABA) neuroreceptors and are known to suppress REM sleep. Withdrawal from benzodiazepines can lead to episodes of increased REM sleep, known as REM sleep rebound, which can cause daytime memory impairment. However, newer benzodiazepine-like agents, such as zolpidem and zaleplon, have been developed with fewer side effects and a lower risk of dependence.

Other sedating agents, such as ethanol and over-the-counter sleeping pills containing antihistamines, are also commonly used. While these may help induce sleep, they can have side effects like daytime sleepiness, cognitive impairment, and anticholinergic effects. It is important to note that the use of ethanol to induce sleep can lead to tolerance, dependence, and a decrease in sleep quality over time.

While sedatives can be effective in treating insomnia, it is crucial to consider their impact on REM sleep and potential side effects. Additionally, non-pharmacological approaches, such as sleep hygiene, hypnosis, and relaxation techniques, have shown therapeutic benefits in treating insomnia without the same degree of side effects as sedatives.

In summary, while sedatives can be useful in treating insomnia, their impact on REM sleep and potential side effects should be carefully considered. It is important to understand the complex relationship between sedatives and sleep stages to make informed decisions about their use in treating sleep disorders.

Frequently asked questions